📝 Acutaas Chemicals Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Acutaas Chemicals Limited reported revenue of ₹330 crore for the quarter ended June 2026 (Q1 FY27), up 59.1% from ₹207 crore in the same quarter last year, and down 23.9% sequentially over the March 2026 quarter.
Net profit rose 70.4% year-on-year to ₹75 crore, from ₹44 crore. Earnings per share (EPS) came in at ₹9.07.
Operating profit stood at ₹113 crore — an operating margin (OPM) of 34.3%, compared with 24.6% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Acutaas Chemicals Limited posted revenue of ₹1,339 crore, a growth of 33.0% over FY25, with a net profit of ₹356 crore (up 121.8% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,462 crore with a net profit of ₹387 crore.
Valuation snapshot
At the current price of ₹3,206.00, ACUTAAS has a market capitalisation of ₹26,248 crore and a trailing P/E of about 67.9.
Within the Specialty Chemicals industry, it is the 8th-largest of the 66 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 32.66%, foreign institutional investors (FIIs) 22.62%, domestic institutional investors (DIIs) 19.40%, the government 0.01%, public shareholders 25.31% of Acutaas Chemicals Limited.